08045804946
Send Inquiry
NAB PACLITERO 100MG INJ
3798.0 INR/Number
Product Details:
- Dosage Form Lyophilized powder for infusion
- Origin of Medicine India
- Packaging Type Vial in carton box
- Life Span 24 months from manufacture
- Brand Name NAB PACLITERO 100MG INJ
- Indication Breast cancer, non-small cell lung cancer, pancreatic cancer
- Salt Composition Paclitaxel 100mg (Protein-bound; Albumin-based)
- Click to View more
X
NAB PACLITERO 100MG INJ Price And Quantity
- 1 Number
- 3798.0 INR/Number
- Neutropenia, peripheral neuropathy, alopecia, nausea, myalgia, arthralgia, mucositis
- 24 months
- Known hypersensitivity to paclitaxel, albumin, or any excipients
- Intravenous
- To be reconstituted with prescribed diluent before administration
- Off-white to yellowish powder
- Administer under supervision of qualified oncologist
- Cytotoxic agent (taxane analogue)
- Taj Pharma
NAB PACLITERO 100MG INJ Product Specifications
- Lyophilized powder for infusion
- India
- Store below 25C. Protect from light
- Anti-cancer therapy
- Vial in carton box
- As directed by physician
- Antineoplastic
- Adults
- Paclitaxel (as human albumin-bound nanoparticle) 100mg
- 24 months from manufacture
- Injection
- Breast cancer, non-small cell lung cancer, pancreatic cancer
- IV infusion only, per protocol
- NAB PACLITERO 100MG INJ
- Paclitaxel 100mg (Protein-bound; Albumin-based)
- 1 vial
- Prescription only
- 1 vial per box
- Neutropenia, peripheral neuropathy, alopecia, nausea, myalgia, arthralgia, mucositis
- 24 months
- Known hypersensitivity to paclitaxel, albumin, or any excipients
- Intravenous
- To be reconstituted with prescribed diluent before administration
- Off-white to yellowish powder
- Administer under supervision of qualified oncologist
- Cytotoxic agent (taxane analogue)
- Taj Pharma
NAB PACLITERO 100MG INJ Trade Information
- Cash Advance (CA), Cash in Advance (CID), Cash on Delivery (COD)
- 1000 Number Per Week
- 2 Days
- No
- Middle East, Africa, Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe
- All India
Product Description
- Active Ingredient: Paclitaxel (100mg).
- Mechanism of Action: It belongs to a class of medicines called anti-microtubule agents (taxanes). It binds to the microtubule structures within cells, preventing them from breaking down during cell division (mitosis), which ultimately stops the cancer cells from growing and kills them.
- Uses: It is used alone or in combination with other treatments for various types of cancer:
- Breast cancer (metastatic or after surgery).
- Non-small cell lung cancer.
- Pancreatic cancer.
- AIDS-related Kaposi's sarcoma (when other treatments have failed).
- Administration: It is a prescription-only medicine administered intravenously (into a vein) by a qualified doctor or nurse in a hospital or clinic setting. It should not be self-administered.
- Manufacturer: Hetero Drugs Ltd..
- Storage: Store in a cool and dry place (typically below 30C or refrigerated at 2-8C, depending on the specific product instructions) and protect from light.
Mechanism of Action and Clinical Benefits
NAB PACLITERO 100MG INJ works by disrupting cell division in cancer cells, ultimately inhibiting tumor growth. Its albumin-bound formulation allows for improved delivery compared to conventional paclitaxel, resulting in enhanced effectiveness and potentially fewer solvent-related reactions. It is widely used for patients diagnosed with breast, non-small cell lung, or pancreatic cancer, offering a valuable therapeutic option in oncology.
Correct Usage and Administration Guidelines
This lyophilized powder must be reconstituted with the prescribed diluent before intravenous infusion. Administration should occur in medical settings under the supervision of a qualified oncologist. The infusion follows specific dosage protocols as directed by a physician and is suitable only for adults with appropriate indications.
Safety and Precautions
NAB PACLITERO 100MG INJ is contraindicated in individuals with known hypersensitivity to paclitaxel, albumin, or any excipients. Common side effects may include neutropenia, peripheral neuropathy, alopecia, nausea, myalgia, arthralgia, and mucositis. It is vital to monitor for adverse reactions and store the product properly to ensure safety and efficacy.
FAQ's of NAB PACLITERO 100MG INJ:
Q: How is NAB PACLITERO 100MG INJ administered?
A: NAB PACLITERO 100MG INJ is administered intravenously after being reconstituted with the prescribed diluent. It should only be given as an infusion under the supervision of a qualified oncologist in a clinical setting.Q: What conditions is NAB PACLITERO 100MG INJ recommended for?
A: This medication is indicated for anti-cancer therapy, specifically in the treatment of breast cancer, non-small cell lung cancer, and pancreatic cancer.Q: When should NAB PACLITERO 100MG INJ not be used?
A: This product must not be used in patients with known hypersensitivity to paclitaxel, albumin, or any excipients present in the formulation.Q: Where should NAB PACLITERO 100MG INJ be stored?
A: The vial should be stored below 25C and protected from light. It must be kept in its original packaging until it is ready to be reconstituted and administered.Q: What are the possible side effects of using NAB PACLITERO 100MG INJ?
A: Common side effects may include neutropenia, peripheral neuropathy, alopecia, nausea, myalgia, arthralgia, and mucositis. Patients are monitored regularly to manage any adverse reactions.Q: How is NAB PACLITERO 100MG INJ reconstituted for use?
A: The lyophilized powder must be reconstituted with the prescribed diluent following the pharmacy or manufacturer's protocol before intravenous administration.Q: What are the benefits of the albumin-bound formulation of NAB PACLITERO 100MG INJ?
A: The albumin-bound nanoparticle formulation of paclitaxel provides improved drug delivery, reducing solvent-related toxicity and enhancing the overall therapeutic effect in cancer treatment.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
Contact Us
- Office No. - 5, Ground Floor, D R Shopping Center, Dattapada Road, Near Hdfc Bank, Borivali East,Mumbai - 400066, Maharashtra, India
- Phone : 08045804946
- Mr Ranjeet Singh (CEO & Founder)
- Mobile : 08045804946
- medisus.pharma007@gmail.com
Send Inquiry
Send SMSMEDISUS PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
